Chearwae, W <br/><br/>
PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.  [electronic resource] 

 -  British journal of cancer  Dec 2008 
 - 2044-53 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6604786  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Antigens, CD--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cytoprotection--drug effects<br/>Epidermal Growth Factor--pharmacology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Glycoproteins--metabolism<br/>Humans<br/>Janus Kinases--metabolism<br/>Neoplastic Stem Cells--metabolism<br/>PPAR gamma--agonists<br/>Peptides--metabolism<br/>Prostaglandin D2--analogs & derivatives<br/>STAT Transcription Factors--metabolism<br/>Signal Transduction--drug effects<br/>Tretinoin--pharmacology